-
1
-
-
49149087664
-
Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib
-
PubMed
-
Braiteh F, Kurzrock R, Johnson FM. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib. J Clin Oncol. 2008;26:3460-2. [PubMed]
-
(2008)
J Clin Oncol
, vol.26
, pp. 3460-3462
-
-
Braiteh, F.1
Kurzrock, R.2
Johnson, F.M.3
-
2
-
-
0025280342
-
Immunolocalization of epidermal growth factor receptors in normal developing human skin
-
PubMed
-
Nanney LB, Stoscheck CM, King LE Jr, et al. Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol. 1990;94:742-8. [PubMed]
-
(1990)
J Invest Dermatol
, vol.94
, pp. 742-748
-
-
Nanney, L.B.1
Stoscheck, C.M.2
King Jr, L.E.3
-
3
-
-
33749015571
-
Pathology and management of dermatologic toxicities associated with anti-EGFR therapy
-
PubMed
-
Fox LP. Pathology and management of dermatologic toxicities associated with anti-EGFR therapy. Oncology (Williston Park). 2006;20:26-34. [PubMed]
-
(2006)
Oncology (Williston Park)
, vol.20
, pp. 26-34
-
-
Fox, L.P.1
-
4
-
-
0031436799
-
EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation
-
PubMed
-
Peus D, Hamacher L, Pittelkow MR. EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation. J Invest Dermatol. 1997;109:751-6. [PubMed]
-
(1997)
J Invest Dermatol
, vol.109
, pp. 751-756
-
-
Peus, D.1
Hamacher, L.2
Pittelkow, M.R.3
-
5
-
-
0035724536
-
Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225
-
PubMed
-
Busam KJ, Capodieci P, Motzer R, et al. Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225. Br J Dermatol. 2001;144:1169-76. [PubMed]
-
(2001)
Br J Dermatol
, vol.144
, pp. 1169-1176
-
-
Busam, K.J.1
Capodieci, P.2
Motzer, R.3
-
6
-
-
0025999449
-
Epidermal growth factor messenger RNA production in human lacrimal gland
-
PubMed
-
Wilson SE, Lloyd SA, Kennedy RH. Epidermal growth factor messenger RNA production in human lacrimal gland Cornea 1991;10:519-524. [PubMed]
-
(1991)
Cornea
, vol.10
, pp. 519-524
-
-
Wilson, S.E.1
Lloyd, S.A.2
Kennedy, R.H.3
-
7
-
-
9644273973
-
Trichomegaly following treatment with gefitinib (ZD1839)
-
PubMed
-
Pascual JC, Banuls J, Belinchon I, et al. Trichomegaly following treatment with gefitinib (ZD1839). Br J Dermatol 2004;151:1111-2. [PubMed]
-
(2004)
Br J Dermatol
, vol.151
, pp. 1111-1112
-
-
Pascual, J.C.1
Banuls, J.2
Belinchon, I.3
-
8
-
-
33845689865
-
Facial hypertrichosis induced by Cetuximab, an anti-EGFR monoclonal antibody
-
PubMed
-
Kerob D, Dupuy A, Reygagne P, et al. Facial hypertrichosis induced by Cetuximab, an anti-EGFR monoclonal antibody. Arch Dermatol. 2006;142:1656-7. [PubMed]
-
(2006)
Arch Dermatol
, vol.142
, pp. 1656-1657
-
-
Kerob, D.1
Dupuy, A.2
Reygagne, P.3
-
10
-
-
34547668744
-
Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: Case reports and a review of literature
-
PubMed
-
Zhang G, Basti S, Jampol LM. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature. Cornea. 2007;26:858-60. [PubMed]
-
(2007)
Cornea
, vol.26
, pp. 858-860
-
-
Zhang, G.1
Basti, S.2
Jampol, L.M.3
-
11
-
-
34247849402
-
Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer
-
PubMed
-
Carser JE, Summers YJ. Trichomegaly of the eyelashes after treatment with erlotinib in non-small cell lung cancer. J Thorac Oncol. 2006;1:1040-1. [PubMed]
-
(2006)
J Thorac Oncol
, vol.1
, pp. 1040-1041
-
-
Carser, J.E.1
Summers, Y.J.2
-
12
-
-
27144459674
-
Trichomegaly of the eyelashes following treatment with cetuximab
-
PubMed
-
Bouché O, Brixi-Benmansour H, Bertin A, et al. Trichomegaly of the eyelashes following treatment with cetuximab. Ann Oncol. 2005;16:1711-2. [PubMed]
-
(2005)
Ann Oncol
, vol.16
, pp. 1711-1712
-
-
Bouché, O.1
Brixi-Benmansour, H.2
Bertin, A.3
-
13
-
-
0038163630
-
Epidermal growth factor receptor inhibition induces trichomegaly
-
PubMed
-
Dueland S, Sauer T, Lund-Johansen F, et al. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol 2003;42:345-6. [PubMed]
-
(2003)
Acta Oncol
, vol.42
, pp. 345-346
-
-
Dueland, S.1
Sauer, T.2
Lund-Johansen, F.3
-
14
-
-
33846459000
-
Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab
-
PubMed
-
Garibaldi DC, Adler RA. Cicatricial ectropion associated with treatment of metastatic colorectal cancer with cetuximab. Ophthal Plast Reconstr Surg. 2007;23:62-3. [PubMed]
-
(2007)
Ophthal Plast Reconstr Surg
, vol.23
, pp. 62-63
-
-
Garibaldi, D.C.1
Adler, R.A.2
-
15
-
-
19844375720
-
Epidermal growth factor receptor mutations in non-small-cell lung cancer: Implications for treatment and tumor biology
-
PubMed
-
Jänne PA, Engelman JA, Johnson BE. Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology. J Clin Oncol. 2005;23:3227-34. [PubMed]
-
(2005)
J Clin Oncol
, vol.23
, pp. 3227-3234
-
-
Jänne, P.A.1
Engelman, J.A.2
Johnson, B.E.3
-
16
-
-
34248385777
-
Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: Subset analysis from the ISEL study
-
PubMed
-
Chang A, Parikh P, Thongprasert S, et al. Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study. J Thorac Oncol. 2006;1:847-55. [PubMed]
-
(2006)
J Thorac Oncol
, vol.1
, pp. 847-855
-
-
Chang, A.1
Parikh, P.2
Thongprasert, S.3
-
17
-
-
33846187218
-
Update on epidermal growth factor receptor mutations in non-small cell lung cancer
-
PubMed
-
Riely GJ, Politi KA, Miller VA, Pao W. Update on epidermal growth factor receptor mutations in non-small cell lung cancer. Clin Cancer Res. 2006;12:7232-41. [PubMed]
-
(2006)
Clin Cancer Res
, vol.12
, pp. 7232-7241
-
-
Riely, G.J.1
Politi, K.A.2
Miller, V.A.3
Pao, W.4
-
18
-
-
4344646459
-
Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer
-
PubMed
-
Perez-Soler R, Chachoua A, Hammond LA, et al. Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer. J Clin Oncol. 2004;22:3238-47. [PubMed]
-
(2004)
J Clin Oncol
, vol.22
, pp. 3238-3247
-
-
Perez-Soler, R.1
Chachoua, A.2
Hammond, L.A.3
-
19
-
-
0037321871
-
EGF signaling patterns the feather array by promoting the interbud fate
-
PubMed
-
Atit, R., R.A. Conlon, and L. Niswander. 2003. EGF signaling patterns the feather array by promoting the interbud fate. Dev. Cell. 4:231-240. [PubMed]
-
(2003)
Dev. Cell
, vol.4
, pp. 231-240
-
-
Atit, R.1
Conlon, R.A.2
Niswander, L.3
-
20
-
-
0030977565
-
Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development
-
PubMed
-
Hansen LA, Alexander N, Hogan ME, et al. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol. 1997;150:1959-75. [PubMed]
-
(1997)
Am J Pathol
, vol.150
, pp. 1959-1975
-
-
Hansen, L.A.1
Alexander, N.2
Hogan, M.E.3
|